MarketPeel
Insider Trading Intelligence
Pricing
…
AS

Artal International Management S.a.

SRRK
10% OWNER · SCHOLAR ROCK HOLDING CORP · CIK 0001522131
FILING MIX · LIFETIME58%/42%
BUYS
29
SELLS
21
TOTAL VALUE
$3.24B
COMPANIES
5
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
23,355,794
AVG SELL PX
$67.69
TRADE KIND
SHOWING 50 / 50
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
19 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Artal International Management S.a., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d19+52.63%+5.35%+0.32%+5.03%+2.76%—
14d19+63.16%+10.60%+0.35%+10.26%+2.95%—
30d19+52.63%+8.24%+1.35%+6.89%+1.25%—
60d19+57.89%+14.79%+2.01%+12.78%+0.01%—
90d19+52.63%+15.67%+4.61%+11.06%+6.43%—
180d19(1 pending)+50.00%+11.44%+10.40%+1.03%-11.72%—
1y19(1 pending)+50.00%+26.41%+19.65%+6.75%-25.12%—
2y19(3 pending)+50.00%+117.59%+41.86%+75.73%-22.39%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SRRK · 11,259,438 shares · as of Oct 12, 2023
02,814,8605,629,7198,444,57911,259,4382023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 21 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAVA
CAVA GROUP, INC.
SALE
3,000,000$90.30$270.90M6,507,990Jun 15, 2026Jun 17, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
20,421,735——175,156,062Apr 30, 2026May 8, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
408,434.7——408,434.7Apr 30, 2026May 8, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
408,434.7——0Apr 30, 2026May 8, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
41,289.58$65.00$2.68M408,434.7Feb 17, 2026Feb 19, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
367,145.12$65.00$23.86M367,145.12Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
1,538,462$1.30$2.00M1,538,462Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,846,154$1.30$5.00M7,362,368Feb 2, 2026Feb 4, 2026 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,553,846$1.30$24.12M154,734,327Feb 2, 2026Feb 4, 2026 ↗View →
CAVA
CAVA GROUP, INC.
SALE
8,000,000$134.13$1.07B9,507,990Nov 18, 2024Nov 20, 2024 ↗View →
CAVA
CAVA GROUP, INC.
SALE
6,000,000$116.36$698.16M17,507,990Aug 26, 2024Aug 28, 2024 ↗View →
CAVA
CAVA GROUP, INC.
SALE
3,000,000$87.25$261.75M23,507,990Jun 5, 2024Jun 7, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,150,922$108.50$124.88M1,150,922May 10, 2024May 14, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
57,546,100——136,180,481May 10, 2024May 14, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
SALE
1,150,922——0May 10, 2024May 14, 2024 ↗View →
CAVA
CAVA GROUP, INC.
SALE
2,000,000$66.25$132.50M26,507,990Mar 21, 2024Mar 25, 2024 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,150,922$108.50$124.88M1,150,922Mar 13, 2024Mar 13, 2024 ↗View →
CAVA
CAVA GROUP, INC.
SALE
3,500,000$53.60$187.60M28,507,990Feb 27, 2024Feb 29, 2024 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
2,189,781$6.85$15.00M11,249,288Oct 12, 2023Oct 16, 2023 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
10,150$8.55$86.7K11,259,438Oct 12, 2023Oct 16, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
861,339——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
1,845,864——6,901,095Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
1,568,865——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
1,568,865——1,568,865Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
1,993,092——32,007,990Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
1,845,864——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
1,993,092——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
3,486,366——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
3,486,366——5,055,231Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
861,339——7,762,434Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
SALE
22,252,464——0Jun 20, 2023Jun 22, 2023 ↗View →
CAVA
CAVA GROUP, INC.
PURCHASE
22,252,464——30,014,898Jun 20, 2023Jun 22, 2023 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
27,775,050$2.60$72.22M78,634,381Jun 5, 2023Jun 5, 2023 ↗View →
WW
WW INTERNATIONAL, INC.
SALE
14,818,300$7.15$105.95M0May 10, 2023May 11, 2023 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
31,557$6.43$202.8K9,059,507Apr 28, 2023May 2, 2023 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE
1,094$9.48$10.4K9,027,950Jan 9, 2023Jan 11, 2023 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
48,774$9.33$455.1K9,029,044Jan 5, 2023Jan 9, 2023 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
130,265$8.04$1.05M8,980,270Oct 25, 2022Oct 27, 2022 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
66,000$7.89$520.8K8,850,005Oct 4, 2022Oct 7, 2022 ↗View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASE
33,971$7.03$238.8K8,784,005Oct 3, 2022Oct 7, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
2,426,070$2.50$6.07M50,859,331Aug 5, 2022Aug 9, 2022 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
16,173,800$2.50$40.43M48,433,261Aug 1, 2022Aug 1, 2022 ↗View →
SEER
SEER, INC.
SALE
252,545$64.15$16.20M5,588,366Feb 1, 2021Feb 3, 2021 ↗View →
LXRX
LEXICON PHARMACEUTICALS, INC.
PURCHASE
10,937,500$3.20$35.00M32,259,461Dec 16, 2020Dec 16, 2020 ↗View →
SEER
SEER, INC.
SALE
249,221——0Dec 8, 2020Dec 10, 2020 ↗View →
SEER
SEER, INC.
PURCHASE
790,000$19.00$15.01M5,840,911Dec 8, 2020Dec 10, 2020 ↗View →
SEER
SEER, INC.
SALE
373,831——0Dec 8, 2020Dec 10, 2020 ↗View →
SEER
SEER, INC.
SALE
474,478——0Dec 8, 2020Dec 10, 2020 ↗View →
SEER
SEER, INC.
SALE
3,953,381——0Dec 8, 2020Dec 10, 2020 ↗View →
SEER
SEER, INC.
PURCHASE
5,050,911——5,050,911Dec 8, 2020Dec 10, 2020 ↗View →
Other insiders · SRRK
Loading peer insiders…
About this filer
CIK 0001522131
ROLE
10% Owner
PRIMARY
SRRK
COMPANIES
5
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001522131DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback